55 related articles for article (PubMed ID: 32154530)
1. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer.
Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R
J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530
[TBL] [Abstract][Full Text] [Related]
2. A Y
Wang Y; Jiang Z; Yuan B; Tian Y; Xiang L; Li Y; Yang Y; Li J; Wu A
Biomater Sci; 2019 Nov; 7(11):4748-4757. PubMed ID: 31508613
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma.
Zhang L; Lu J; Qiu L
Int J Nanomedicine; 2016; 11():5205-5220. PubMed ID: 27785023
[TBL] [Abstract][Full Text] [Related]
4. Chitosan-alginate BSA-gel-capsules for local chemotherapy against drug-resistant breast cancer.
Shen H; Li F; Wang D; Yang Z; Yao C; Ye Y; Wang X
Drug Des Devel Ther; 2018; 12():921-934. PubMed ID: 29719378
[TBL] [Abstract][Full Text] [Related]
5. A nanomedicine composed of polymer-ss-DOX and polymer-Ce6 prodrugs with monoclonal antibody targeting effect for anti-tumor chemo-photodynamic synergetic therapy.
Yu L; Zhang M; He J; Sun X; Ni P
Acta Biomater; 2024 Apr; 179():272-283. PubMed ID: 38460931
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.
Zhou Y; Wang S; Ying X; Wang Y; Geng P; Deng A; Yu Z
Int J Nanomedicine; 2017; 12():6153-6168. PubMed ID: 28883726
[TBL] [Abstract][Full Text] [Related]
7. Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.
Huang Q; Cai T; Li Q; Huang Y; Liu Q; Wang B; Xia X; Wang Q; Whitney JCC; Cole SPC; Cai Y
Drug Deliv; 2018 Nov; 25(1):1056-1066. PubMed ID: 29695174
[TBL] [Abstract][Full Text] [Related]
8. Magnetic And pH Dual-Responsive Nanoparticles For Synergistic Drug-Resistant Breast Cancer Chemo/Photodynamic Therapy.
Wang D; Li X; Li X; Kang A; Sun L; Sun M; Yang F; Xu C
Int J Nanomedicine; 2019; 14():7665-7679. PubMed ID: 31571870
[TBL] [Abstract][Full Text] [Related]
9. Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo.
Liu T; Jia T; Yuan X; Liu C; Sun J; Ni Z; Xu J; Wang X; Yuan Y
Int J Nanomedicine; 2016; 11():2235-50. PubMed ID: 27284243
[TBL] [Abstract][Full Text] [Related]
10. Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers.
Patra A; Satpathy S; Shenoy AK; Bush JA; Kazi M; Hussain MD
Int J Nanomedicine; 2018; 13():2869-2881. PubMed ID: 29844670
[TBL] [Abstract][Full Text] [Related]
11. X-ray-Induced Cherenkov Optical Triggering of Caged Doxorubicin Released to the Nucleus for Chemoradiation Activation.
Yao C; Li J; Cao X; Gunn JR; Wu M; Jiang S; Pogue BW
ACS Appl Mater Interfaces; 2020 Oct; 12(40):44383-44392. PubMed ID: 32914957
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of cathepsin B cleavage albumin-binding SN38 prodrug in breast cancer.
Lu Y; Huang Y; Jin J; Yu J; Lu W; Zhu S
Bioorg Chem; 2024 Jun; 147():107370. PubMed ID: 38621338
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoassemblies entrapping curcumin overcome multidrug resistance in ovarian cancer.
Gou Q; Liu L; Wang C; Wu Q; Sun L; Yang X; Xie Y; Li P; Gong C
Colloids Surf B Biointerfaces; 2015 Feb; 126():26-34. PubMed ID: 25543980
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled nanocomplex between polymerized phenylboronic acid and doxorubicin for efficient tumor-targeted chemotherapy.
Lee J; Kim J; Lee YM; Park D; Im S; Song EH; Park H; Kim WJ
Acta Pharmacol Sin; 2017 Jun; 38(6):848-858. PubMed ID: 28414203
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of prodrugs in breast cancer using metabolic glycoengineering and the tetrazine ligation bioorthogonal reaction.
Mitry MMA; Dallas ML; Boateng SY; Greco F; Osborn HMI
Bioorg Chem; 2024 Jun; 147():107304. PubMed ID: 38643563
[TBL] [Abstract][Full Text] [Related]
16. The siRNAsome: A Cation-Free and Versatile Nanostructure for siRNA and Drug Co-delivery.
Zheng M; Jiang T; Yang W; Zou Y; Wu H; Liu X; Zhu F; Qian R; Ling D; McDonald K; Shi J; Shi B
Angew Chem Int Ed Engl; 2019 Apr; 58(15):4938-4942. PubMed ID: 30737876
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery.
Chen J; Ratnayaka S; Alford A; Kozlovskaya V; Liu F; Xue B; Hoyt K; Kharlampieva E
ACS Nano; 2017 Mar; 11(3):3135-3146. PubMed ID: 28263564
[TBL] [Abstract][Full Text] [Related]
18. Folic acid grafted mixed polymeric micelles as a targeted delivery strategy for tamoxifen citrate in treatment of breast cancer.
Nasr M; Hashem F; Teiama M; Tantawy N; Abdelmoniem R
Drug Deliv Transl Res; 2024 Apr; 14(4):945-958. PubMed ID: 37906415
[TBL] [Abstract][Full Text] [Related]
19. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy.
Santra S; Kaittanis C; Santiesteban OJ; Perez JM
J Am Chem Soc; 2011 Oct; 133(41):16680-8. PubMed ID: 21910482
[TBL] [Abstract][Full Text] [Related]
20. Protein-Engineered Nanoscale Micelles for Dynamic
Hill LK; Frezzo JA; Katyal P; Hoang DM; Ben Youss Gironda Z; Xu C; Xie X; Delgado-Fukushima E; Wadghiri YZ; Montclare JK
ACS Nano; 2019 Mar; 13(3):2969-2985. PubMed ID: 30758189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
